Response to Comments: Platelet Rich Plasma

This document is a response-to-comments summary for Novitas Solutions' Proposed LCD DL39068 (Platelet Rich Plasma) and does not itself specify clinical coverage criteria, limitations, documentation, or frequency limits. For actionable coverage criteria and requirements, refer to the final LCD DL39068 (Platelet Rich Plasma).